Medtronic Earns CE Mark for Deep Brain Stimulation Software
Tuesday, August 9, 2016
Medtronic ($MDT) has earned a CE mark for its SureTune2 software. The tech offers physicians patient-specific visualizations which help them to “tune” a patient’s deep brain stimulation (DBS) therapy.
DBS therapy is a targeted treatment that offers specific symptom control through mild electrical stimulation in the brain. “The brain targets are stimulated through lead(s) inserted into the brain and connected to an implantable neurostimulator through extensions running under the skin,” Medtronic explained in the announcement. “A medical professional uses an external programmer to set and adjust stimulation settings.”